100 related articles for article (PubMed ID: 1370768)
1. Plasma levels of HGF in rats treated with tumor promoters.
Lindroos P; Tsai WH; Zarnegar R; Michalopoulos GK
Carcinogenesis; 1992 Jan; 13(1):139-41. PubMed ID: 1370768
[TBL] [Abstract][Full Text] [Related]
2. Blockade of alpha-1 adrenergic receptor inhibits hepatic DNA synthesis stimulated by tumor promoters.
Tsai WH; Cruise JL; Michalopoulos GK
Carcinogenesis; 1989 Jan; 10(1):73-8. PubMed ID: 2463115
[TBL] [Abstract][Full Text] [Related]
3. Response of phenobarbital- and ciprofibrate-exposed hepatocytes to growth factors in type I collagen gels.
Lindroos P; Michalopoulos GK
Carcinogenesis; 1993 Apr; 14(4):731-5. PubMed ID: 7682481
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with hepatic tumor promoters inhibits mitogenic responses of hepatocytes to acidic fibroblast growth factor and hepatocyte growth factor.
Tsai WH; Zarnegar R; Michalopoulos GK
Cancer Lett; 1991 Aug; 59(2):103-8. PubMed ID: 1715812
[TBL] [Abstract][Full Text] [Related]
5. Zonal differences in DNA synthesis activity and cytochrome P450 gene expression in livers of male F344 rats treated with five nongenotoxic carcinogens.
Chen ZY; White CC; He CY; Liu YF; Eaton DL
J Environ Pathol Toxicol Oncol; 1995; 14(2):83-99. PubMed ID: 9372837
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions.
Matsumoto K; Nakamura T
Crit Rev Oncog; 1992; 3(1-2):27-54. PubMed ID: 1312869
[TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone inhibits DNA synthesis of rat hepatocytes induced by partial hepatectomy or mitogen (ciprofibrate).
Rao MS; Subbarao V
Cell Prolif; 1997 Jan; 30(1):1-5. PubMed ID: 9332491
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the effects of human placental HGF on rat hepatocytes.
Hernandez J; Zarnegar R; Michalopoulos GK
J Cell Physiol; 1992 Jan; 150(1):116-21. PubMed ID: 1370501
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of DNA synthesis in primary rat hepatocyte cultures by liver tumor promoters: interactions with other growth factors.
Yusof YA; Edwards AM
Carcinogenesis; 1990 May; 11(5):761-70. PubMed ID: 1692266
[TBL] [Abstract][Full Text] [Related]
10. Expression of growth factors and growth factor receptors in the liver of C57BL/10J mice following administration of phenobarbitone.
Orton TC; Doughty SE; Kalinowski AE; Lord PG; Wadsworth PF
Carcinogenesis; 1996 May; 17(5):973-81. PubMed ID: 8640946
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of "injurin," an inducer of expression of the gene for hepatocyte growth factor.
Matsumoto K; Tajima H; Hamanoue M; Kohno S; Kinoshita T; Nakamura T
Proc Natl Acad Sci U S A; 1992 May; 89(9):3800-4. PubMed ID: 1533283
[TBL] [Abstract][Full Text] [Related]
12. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines.
Efimova EA; Glanemann M; Liu L; Schumacher G; Settmacher U; Jonas S; Langrehr JM; Neuhaus P; Nüssler AK
Eur Surg Res; 2004; 36(5):300-7. PubMed ID: 15359093
[TBL] [Abstract][Full Text] [Related]
13. Cell density-dependent regulation of albumin synthesis and DNA synthesis in rat hepatocytes by hepatocyte growth factor.
Takehara T; Matsumoto K; Nakamura T
J Biochem; 1992 Sep; 112(3):330-4. PubMed ID: 1429519
[TBL] [Abstract][Full Text] [Related]
14. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
Perrone CE; Shao L; Williams GM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness of hepatocytes to epidermal growth factor, transforming growth factor-beta and norepinephrine during treatment with xenobiotic hepatic tumor promoters.
Tsai WH; Michalopoulos GK
Cancer Lett; 1991 Apr; 57(1):83-90. PubMed ID: 1709063
[TBL] [Abstract][Full Text] [Related]
16. p53 May positively regulate hepatocyte proliferation in rats.
Inoue Y; Tomiya T; Yanase M; Arai M; Ikeda H; Tejima K; Ogata I; Kimura S; Omata M; Fujiwara K
Hepatology; 2002 Aug; 36(2):336-44. PubMed ID: 12143041
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats.
Hasuike S; Ido A; Uto H; Moriuchi A; Tahara Y; Numata M; Nagata K; Hori T; Hayashi K; Tsubouchi H
J Gastroenterol Hepatol; 2005 Nov; 20(11):1753-61. PubMed ID: 16246197
[TBL] [Abstract][Full Text] [Related]
18. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat.
Pediaditakis P; Lopez-Talavera JC; Petersen B; Monga SP; Michalopoulos GK
Hepatology; 2001 Oct; 34(4 Pt 1):688-93. PubMed ID: 11584364
[TBL] [Abstract][Full Text] [Related]
19. Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats.
Kaido T; Yoshikawa A; Seto S; Yamaoka S; Sato M; Ishii T; Imamura M
Hepatology; 1998 Sep; 28(3):756-60. PubMed ID: 9731569
[TBL] [Abstract][Full Text] [Related]
20. Effect of intracellular pH and two growth factors, epidermal growth factor and human hepatocyte growth factor, on DNA synthesis in non-regenerating and regenerating hepatocytes and hepatoma cells.
Yada K
Osaka City Med J; 1994 Dec; 40(2):53-69. PubMed ID: 7862427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
